US Patent Issued to YEDITEPE UNIVERSITESI on June 17 for "Use of mutant P53 gene targeted lead borate nanoparticles in cancer treatment and production method of these nanoparticles" (Turkish Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,777, issued on June 17, was assigned to YEDITEPE UNIVERSITESI (Istanbul).

"Use of mutant P53 gene targeted lead borate nanoparticles in cancer treatment and production method of these nanoparticles" was invented by Fikrettin Sahin (Istanbul), Pakize Neslihan Tasli (Istanbul), Oguz Kaan Kirbas (Istanbul), Taha Bartu Hayal (Istanbul), Batuhan Turhan Bozkurt (Istanbul), Berna Bulbul (Balikesir, Turkey) and Seda Beyaz (Balikesir, Turkey).

According to the abstract* released by the U.S. Patent & Trademark Office: "Use of nano-sized lead borate compounds for treatment purposes due to their selective anticancer activity on p53 mutant breast cancer cell line, T47D is disclosed. The metho...